当前位置:首页 - 行情中心 - 赛升药业(300485) - 财务分析 - 现金流量表

赛升药业

(300485)

  

流通市值:34.01亿  总市值:59.82亿
流通股本:2.74亿   总股本:4.82亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金350,257,520.72228,375,313.04110,077,362.61436,907,932.47
  收到的税费返还2,346,593.292,346,593.29-2,188,070.83
  收到其他与经营活动有关的现金1,417,318.07288,639.15102,289.858,714,494.31
  经营活动现金流入小计354,021,432.08231,010,545.48110,179,652.46447,810,497.61
  购买商品、接受劳务支付的现金75,504,042.8449,541,537.8830,634,498.7274,942,190.41
  支付给职工以及为职工支付的现金57,841,323.9338,750,125.4619,762,616.1872,426,426.95
  支付的各项税费44,020,780.2630,589,303.668,080,848.0523,896,624.09
  支付其他与经营活动有关的现金146,213,331.0982,787,678.4641,017,924.89140,571,309.96
  经营活动现金流出小计323,579,478.12201,668,645.4699,495,887.84311,836,551.41
  经营活动产生的现金流量净额30,441,953.9629,341,900.0210,683,764.62135,973,946.2
二、投资活动产生的现金流量:
  收回投资收到的现金41,364,233.9330,762,094.12-66,187,973.86
  取得投资收益收到的现金32,728,369.475,146,725.994,903,575.0825,216,340.65
  处置固定资产、无形资产和其他长期资产收回的现金净额180,000180,000159,292.04-
  收到的其他与投资活动有关的现金1,879,895,582.03490,379,143.52465,945,800658,027,917.97
  投资活动现金流入小计1,954,168,185.43526,467,963.63471,008,667.12749,432,232.48
  购建固定资产、无形资产和其他长期资产支付的现金45,066,852.5529,547,965.454,563,256.83101,126,692.04
  投资支付的现金---15,000,000
  支付其他与投资活动有关的现金1,945,170,852.8524,809,000493,009,000808,662,500
  投资活动现金流出小计1,990,237,705.35554,356,965.45497,572,256.83924,789,192.04
  投资活动产生的现金流量净额-36,069,519.92-27,889,001.82-26,563,589.71-175,356,959.56
三、筹资活动产生的现金流量:
  吸收投资收到的现金---4,700,000
  取得借款收到的现金19,987,800---
  筹资活动现金流入平衡项目0--0
  筹资活动现金流入小计19,987,800--4,700,000
  分配股利、利润或偿付利息支付的现金---10,587,354.35
  筹资活动现金流出平衡项目---0
  筹资活动现金流出小计---10,587,354.35
  筹资活动产生的现金流量净额平衡项目0--0
  筹资活动产生的现金流量净额19,987,800---5,887,354.35
四、汇率变动对现金及现金等价物的影响-298,613.9-105,771.77-36,203.3368,603.89
五、现金及现金等价物净增加额14,061,620.141,347,126.43-15,916,028.39-44,901,763.82
  加:期初现金及现金等价物余额75,262,690.3175,262,690.3175,262,690.31120,164,454.13
  期末现金及现金等价物余额89,324,310.4576,609,816.7459,346,661.9275,262,690.31
补充资料:
  净利润-45,755,010.5--76,874,137.69
  资产减值准备-1,143,047.16-1,324,236.93
  固定资产和投资性房地产折旧-22,807,516.02-42,774,425.64
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-22,807,516.02-42,774,425.64
  无形资产摊销-1,891,989.81-4,126,947.51
  处置固定资产、无形资产和其他长期资产的损失--111,881.57--
  固定资产报废损失---48,624.87
  公允价值变动损失--38,542,068.26-56,509,203.23
  财务费用----6.42
  投资损失--7,452,845.57-51,620,778.39
  递延所得税-5,902,576.36--19,342,454.26
  其中:递延所得税资产减少--170,974.58-636,073.82
    递延所得税负债增加-6,073,550.94--19,978,528.08
  存货的减少--1,524,844.08-22,359,302.56
  经营性应收项目的减少-3,609,797.82-14,709,258.34
  经营性应付项目的增加--4,311,804.24-37,978,868.7
  其他---388,086.35
  现金的期末余额-76,609,816.74-75,262,690.31
  减:现金的期初余额-75,262,690.31-120,164,454.13
  现金及现金等价物的净增加额-1,347,126.43--44,901,763.82
公告日期2025-10-242025-08-222025-04-242025-03-29
审计意见(境内)标准无保留意见
TOP↑